bladder tumor

23
THE URINARY BLADDER TUMORS Dr. Ali Kamal M. Sami M.B.Ch.B. M.A.U.A . F.I.B.M.S. M.I.U.A .

Upload: hussein-ali-ramadhan

Post on 01-Jun-2015

874 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Bladder tumor

THE URINARY BLADDER TUMORS

Dr. Ali Kamal M. SamiM.B.Ch.B. M.A.U.A.F.I.B.M.S. M.I.U.A.

Page 2: Bladder tumor

NEOPLASM OF BLADDER

Ninety-five per cent of primary bladder tumours originate in the epithelium;

the remainder arise from connective tissue angioma, myoma, fibroma and

sarcoma. )secondary tumours of the bladder from the sigmoid and rectum, the prostate, the uterus or ovary ,

Page 3: Bladder tumor

PathologyBenign papillary tumours. The papilloma consists of a single frond with a central vascular core with villi; it looks like a red sea-anemone .

Page 4: Bladder tumor

Carcinoma arising within the bladder may be of three cell types: Transitional 90% Squamous 5% Adenocarcinoma 1-2%, which arises either from the urachal remnant.

Carcinoma of the

bladder

Page 5: Bladder tumor

Transitional cell carcinoma (TCC):

Occupations which have been reported to have a significantly excess risk of bladder cancer are shown belowOccupations with an excess risk of bladder cancer

1. Textile workers2. Dye workers3. Tire rubber and cable workers4. Petrol workers5. Leather workers6. Shoe manufacturers and cleaners7. Painters8. Hairdressers9. Lorry drivers10. Drill press operators11. Chemical workers12. Rodent exterminators and sewage workers

Cigarette smoking is associated with a two to three fold excess risk.In areas

where S. haematobium is endemic bladder cancer is more common, and this tends to be squamous

Page 6: Bladder tumor

Tumour staging and grading Study of the biological behaviour of transitional cell cancer of the bladder shows that they fall into the three following groups.• Non muscle invasive tumours (pTa) and (pT1) account for 70%. These tumours may be single or multiple. Histological examination may reveal invasion of the lamina propria (pT1) but not of the muscle or no invasion of lamina propria (pTa) .• Muscle invasive disease(T2)(T3)(T4) (accounts for 25 per cent of new cases). Such tumours carry a much worse prognosis as they are subject to local invasion and distant metastasis.• Flat, noninvasive carcinoma in situ (CIS) accounts for 5%.

Page 7: Bladder tumor

Superficial bladder cancer (pTa and pT1)

These are usually papillary tumours which grow in an exophytic fashion into the bladder lumen .

They may be single or multiple and may appear pedunculated arising on a stalk with a narrow base,

but if the’ tumours are less well differentiated they are more solid with a wider base .

The most common sites for superficial tumours are the trigone and lateral walls of the bladder.

Page 8: Bladder tumor

Muscle invasive transitional cell carcinoma

The tumour with muscle invasion is nearly always solid. These tumours are often large and broad based, having an irregular, ugly, sometimes ulcerated, appearance within the bladder. The incidence of metastases, whether from lymphatic invasion in the pelvis or blood-born to the lung, liver or bones, is much more common and will cause the death of 3 0—50 per cent of patients.

Page 9: Bladder tumor

In situ carcinom

a

The histological appearance of

irregularly arranged cells with large

nuclei and a high mitotic index replacing the normally well

ordered urothelium is known as

carcinoma in situ.

Page 10: Bladder tumor

Pure squamous cell carcinoma of the bladder

Squamous cell tumours tend to be solid and are nearly always associated with muscle invasion. This is the most prevalent form of bladder cancer in areas where bilharzia is endemic. Squamous cell tumours may be associated with chronic irritation caused by stone disease in the bladder as a result of metaplasia.

Page 11: Bladder tumor

Pure adenocarcinomaThis accounts for approximately 1—2 per cent of bladder cancer. It usually arises in the fundus of the bladder at the site of the urachal remnant.

Page 12: Bladder tumor

Clinical features1. Painless Intermittent haematuria is by far the most

common symptom and should be regarded as indicative of a bladder carcinoma until proven otherwise.

2. Constant pain in the pelvis usually heralds extravesical spread.

3. There is often frequency and discomfort associated with urination.

4. Pain in the loin or pyelonephritis may indicate ureteric obstruction and hydronephrosis.

5. A late manifestation is nerve involvement causing pain referred to the suprapubic region, groins, perineum, anus and into the thighs.

Page 13: Bladder tumor

Investigation•Urine. Urine should be cultured and examined cytologically for malignant cells. This is not a good screening test for patients with haematuria as, particularly with low-grade tumours, malignant cells may not be identified .•Blood tests like (Hb , S.electrolytes , B.Urea).•IVU. -The most common radiological sign is a filling defect. -Hydronephrosis may occur if a superficial tumour grows up the intramural ureter or if direct invasion of the ureteric wall occurs.•- Ultrasound scanning should be carried out if the kidney is nonfunctioning.•Cystourethroscopy. Cystourethroscopy is the mainstay of diagnosis and should always be performed on patients with haematunia. It can be done with a rigid instrument under general anaesthesia or with a flexible instrument under local anaesthesia. The urethra is inspected at the initial insertion of the instrument (urethroscopy) and the bladder is then examined in a systematic fashion (cystoscopy).•Bimanual examination. A bimanual examination with the patient fully relaxed under general anaesthesia should be performed both before and after endoscopic surgical treatment of these tumours.

Page 14: Bladder tumor

Treatment of Carcinoma of the bladder

Page 15: Bladder tumor

•Noninvasive tumours

Endoscopic surgery (TURBT)(Trans Urethral Resection of Bladder Tumor)

The tumour should be carefully resected in layers using a resectoscope. The base of the

tumour is sent separately for histological examination. Small biopsies are taken near to and

distant from the primary lesion to diagnose unsuspected CIS.

The bimanual examination is repeated at the end of each endoscopic procedure.

Follow-up. Most urologists agree that patients with a single, low- or medium-grade pTa

tumour can safely be treated by resection alone and followed up by means of regular

cystoscopies.

The resection may be followed by a 6-week course of intravesical chemotherapy with

mitomycin C, adriamycin or epirubicin.

Others will treat such patients by means of endoscopic treatment followed by intravesical

immunotherapy with intravesical bacillus of Calmette and Guérin (BCG).

Follow-up cystoscopies are essential; they may be carried out by means of local anaesthesia

with a flexible cystoscope on by means of general anaesthesia if the urologist feels that the

patient has a high risk of recurrence.

They are usually done in 3 months intervals in first year.

6 months intervals in the second year.

Yearly intervals for the next 3 years.

Page 16: Bladder tumor

Intravesical chemotherapy and immunotherapyVarious agents have been used as chemotherapy. These include •Thiotepa.•mitomycin C.•epirubicin.•adriamycin.Immunotherapy agent includes:BCG is now frequently used as intravesical immunotherapy

Page 17: Bladder tumor

Open surgical excisionThis should be totally avoided. If by some error a bladder containing a tumour is entered, then the tumour may be removed with a diathermy needle and the base coagulated and the bladder closed. Postoperative radiotherapy to the wound will diminish the chance of tumour implantation.

Page 18: Bladder tumor

2.Invasive tumours•Radical cystectomy.•Radical radiotherapy.•Combination of the two.•Primary surgery(radical cystectomy) followed by a combination of agents using cis-platinum, methotrexate, adriamycin and vinblastine (MVAC)

Page 19: Bladder tumor

Radiotherapy

Deep external beam X-ray therapy. External beam radiotherapy is

usually given by means of high-powered linear accelerators. Radical

radiotherapy giving 60 Gy over a 4—6-week

period will produce a 40—50 per cent complete

response .

Local radiotherapy. For small invasive

lesions, local radiotherapy can be delivered by open

placement of a radioactive tantalum

wire. It is used infrequently today.

Page 20: Bladder tumor

SurgeryPartial cystectomy. This should be limited to the treatment of small adenocarcinomas at the dome of the bladder.Radical cystectomy and pelvic lymphadenectomy. This is now standard treatment for localised pT2—pT3 disease without evidence of secondary spread.OperationThe radical cystectomy Needs diversion of urine by:•Ileal conduit.•Ureterosigmodostomy:Orthotopic ileal neobladder

Page 21: Bladder tumor

LeukoplakiaThis condition is simply squamous metaplasia of the bladder. Profuse production of keratin may result in the passing of white particles in the urine. It cannot be treated easily. Localised areas may be resected endoscopically.

Diffuse leucoplakia of the bladder is premalignant and results in squamous bladder cancer. Careful cystoscopic assessment is required. The condition may require cystectomy.

Page 22: Bladder tumor

EndometriosisEndometriosis within the bladder wall is rare, but can have the appearance of a vascular bladder tumour or a tumour which contains chocolate-coloured or bluish cysts. The swelling enlarges and bleeds during menstruation. If medical management fails, by means of danazol or luteinising hormone-releasing agonists (LHRH), further treatment is usually by means of partial cystectomy or full-thickness endoscopic resection, depending on its site. The condition may be part of more widespread disease. Endometriosis is also a cause of ureteric stricture.

Page 23: Bladder tumor

THANK YOU